Answers are grounded in this paper and cite their sources.
In vitro screen reveals broad antibody affinity maturation against diverse SARS-CoV-2 variants, suggesting increased resistance to future viral mutations.
Antibodies suffer from resistance mutations in their targets, which diminishes their efficacy. Most antibody library screens use a single antigen yet should ideally use many antigens to ensure that the hits have broad-binding capacity. As a test case, we used the receptor-binding domain (RBD) of SARS COV-2 and CR3022 as the starting antigen/antibody pair. We screened a CR3022 library against a large panel of RBDs (94) and isolated a hit (C8) that has improved affinity for 95/102 tested RBDs. C8 has improved affinity to variants unseen in the library screening, indicating that C8 is more resistant to future antigen variants. This study, to our knowledge, represents the largest interaction screen (107) performed to date using synthetic agglutination in yeast.
No takes yet. Share an insight, caveat, or question.
Hard et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: